PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
REGN vs. VRTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

REGN vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

2,000.00%4,000.00%6,000.00%8,000.00%10,000.00%12,000.00%JuneJulyAugustSeptemberOctoberNovember
7,283.51%
2,487.22%
REGN
VRTX

Returns By Period

In the year-to-date period, REGN achieves a -13.83% return, which is significantly lower than VRTX's 14.45% return. Over the past 10 years, REGN has underperformed VRTX with an annualized return of 6.25%, while VRTX has yielded a comparatively higher 15.45% annualized return.


REGN

YTD

-13.83%

1M

-24.92%

6M

-22.95%

1Y

-4.99%

5Y (annualized)

17.05%

10Y (annualized)

6.25%

VRTX

YTD

14.45%

1M

-4.42%

6M

4.60%

1Y

35.77%

5Y (annualized)

17.32%

10Y (annualized)

15.45%

Fundamentals


REGNVRTX
Market Cap$90.22B$126.19B
EPS$40.39-$1.91
PEG Ratio1.231.32
Total Revenue (TTM)$13.85B$10.61B
Gross Profit (TTM)$11.95B$9.14B
EBITDA (TTM)$4.53B-$147.50M

Key characteristics


REGNVRTX
Sharpe Ratio-0.211.36
Sortino Ratio-0.142.20
Omega Ratio0.981.28
Calmar Ratio-0.122.79
Martin Ratio-0.476.05
Ulcer Index9.57%5.51%
Daily Std Dev21.13%24.44%
Max Drawdown-91.81%-91.77%
Current Drawdown-37.02%-9.88%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.4

The correlation between REGN and VRTX is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

REGN vs. VRTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for REGN, currently valued at -0.21, compared to the broader market-4.00-2.000.002.00-0.211.36
The chart of Sortino ratio for REGN, currently valued at -0.14, compared to the broader market-4.00-2.000.002.004.00-0.142.20
The chart of Omega ratio for REGN, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.28
The chart of Calmar ratio for REGN, currently valued at -0.12, compared to the broader market0.002.004.006.00-0.122.79
The chart of Martin ratio for REGN, currently valued at -0.47, compared to the broader market0.0010.0020.0030.00-0.476.05
REGN
VRTX

The current REGN Sharpe Ratio is -0.21, which is lower than the VRTX Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of REGN and VRTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.21
1.36
REGN
VRTX

Dividends

REGN vs. VRTX - Dividend Comparison

Neither REGN nor VRTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

REGN vs. VRTX - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for REGN and VRTX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-37.02%
-9.88%
REGN
VRTX

Volatility

REGN vs. VRTX - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) and Vertex Pharmaceuticals Incorporated (VRTX) have volatilities of 10.24% and 9.96%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
10.24%
9.96%
REGN
VRTX

Financials

REGN vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items